• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

How Private Equity Oversees the Ethics of Drug Research

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Walt Bogdanich
Author: Walt Bogdanich

Written by

Walt Bogdanich

in

Clinical Trials, Conflicts of Interest, Drugs (Pharmaceuticals), Ethics and Official Misconduct, GLP-1 RAs (Drug), Mergers, Acquisitions and Divestitures, Novo Nordisk A/S, Ozempic (Drug), Private Equity, Regulation and Deregulation of Industry, Research
←An American Way of Dress
More Retirees Are Living on Less, and Losing a Means of Help to Pay for Medicare→

More posts

  • As Oil Prices Rise, Trump’s War With Iran Becomes a Worldwide Economic Hazard

  • Perpetual futures grow beyond crypto

  • Travis Kelce to return, and the Chiefs (naturally) appear to be his preferred destination

  • Trump says it’s ‘too soon’ to talk about seizing Iran’s oil — but doesn’t rule it out

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube